We are live on ! Find out more
DARE icon

Dare Bioscience

29 hedge funds and large institutions have $7.16M invested in Dare Bioscience in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.15% less ownership

Funds ownership: 8.27% → 8.12% (-0.15%)

3% less funds holding

Funds holding: 30 → 29 (-1)

17% less capital inflows, than outflows

Capital inflows: $464K | Capital outflows: $556K

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
7
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DARE Hedge Fund Activity: Q1 2023 in Review

29 of the 6,291 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2023, worth a combined $7.16M — up 23% from $5.82M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of DARE and 3 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 7 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $271K. The largest seller was Millennium Management, exiting entirely with an estimated $101K sold.

  • 29 institutional investors held Dare Bioscience (DARE) as of Q1 2023, down from 30 in Q4 2022.
  • Funds reported $7.16M of Dare Bioscience stock for Q1 2023, up 23% quarter-over-quarter.
  • 3 funds opened new Dare Bioscience positions in Q1 2023 and 4 closed out, a net change of -1 holder.
  • The largest Dare Bioscience buyer in Q1 2023 was Citadel Advisors, an estimated $271K added.
  • The largest Dare Bioscience seller in Q1 2023 was Millennium Management, an estimated $101K sold.

Based on aggregated 13F filings for Q1 2023.